Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Sales | 474 | 441 | 326 | 722 | 602 |
| Cost of Goods | 199 | 183 | 149 | 280 | 281 |
| Gross Profit | 275 | 258 | 177 | 442 | 321 |
| Operating Expenses | 1,173 | 1,258 | 1,290 | 1,433 | 1,626 |
| Operating Income | -699 | -817 | -964 | -711 | -1,024 |
| Interest Expense | 52 | 41 | 38 | 24 | 8 |
| Other Income | -5 | 1 | 0 | 0 | 0 |
| Pre-tax Income | -756 | -857 | -1,002 | -735 | -1,032 |
| Net Income Continuous | -756 | -857 | -1,002 | -735 | -1,032 |
| Net Income | $-756 | $-857 | $-1,002 | $-735 | $-1,032 |
| EPS Basic Total Ops | N/A | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | N/A | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -0.01 | -0.01 | -0.01 | N/A |
| EBITDA(a) | $-661 | $-781 | $-927 | $-674 | $-1,009 |